{"transactions":[{"id":1352333,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-11-25T21:28:21.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":18641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest one year from date of grant."}],"balance_after":18641,"derivative":{"exercise_price":8.24,"expiration_date":"2034-11-21","underlying":"Common Shares","underlying_shares":18641},"source":{"system":"sec-edgar","filing":"0001600620-24-000118","document":"wk-form4_1732570094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000118/wk-form4_1732570094.xml","form_type":"4"}},{"id":1352332,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-11-25T21:28:21.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":12135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant."}],"balance_after":56499,"source":{"system":"sec-edgar","filing":"0001600620-24-000118","document":"wk-form4_1732570094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000118/wk-form4_1732570094.xml","form_type":"4"}},{"id":1505074,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T20:11:31.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":4946,"price":5.74,"value":28390.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on May 19, 2023."}],"balance_after":44364,"source":{"system":"sec-edgar","filing":"0001600620-24-000074","document":"wk-form4_1716408679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000074/wk-form4_1716408679.xml","form_type":"4"}},{"id":1880750,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-23T21:19:49.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":15234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in twelve equal monthly installments commencing on June 19, 2023."}],"balance_after":15234,"derivative":{"exercise_price":10.74,"expiration_date":"2033-05-19","underlying":"Common Stock","underlying_shares":15234},"source":{"system":"sec-edgar","filing":"0001600620-23-000022","document":"wk-form4_1684876777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000022/wk-form4_1684876777.xml","form_type":"4"}},{"id":1880749,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-23T21:19:49.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."}],"balance_after":0,"derivative":{"exercise_date":"2023-05-18","underlying":"Common Stock","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001600620-23-000022","document":"wk-form4_1684876777.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000022/wk-form4_1684876777.xml","form_type":"4"}},{"id":1880748,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:19:49.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":8733,"price":11.26,"value":98333.58,"ownership":{"direct":true},"balance_after":49310,"source":{"system":"sec-edgar","filing":"0001600620-23-000022","document":"wk-form4_1684876777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000022/wk-form4_1684876777.xml","form_type":"4"}},{"id":1880747,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:19:49.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":9310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant."}],"balance_after":58043,"source":{"system":"sec-edgar","filing":"0001600620-23-000022","document":"wk-form4_1684876777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000022/wk-form4_1684876777.xml","form_type":"4"}},{"id":1880746,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:19:49.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":8733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date."}],"balance_after":48733,"source":{"system":"sec-edgar","filing":"0001600620-23-000022","document":"wk-form4_1684876777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062023000022/wk-form4_1684876777.xml","form_type":"4"}},{"id":2209088,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-11T10:16:31.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date."}],"balance_after":0,"derivative":{"exercise_price":3.62,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-22-018767","document":"wf-form4a_165753457810786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022018767/wf-form4a_165753457810786.xml","form_type":"4/A","original_submission_date":"2022-05-20"}},{"id":2209087,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T10:16:31.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":10000,"price":3.62,"value":36200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001628280-22-018767","document":"wf-form4a_165753457810786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022018767/wf-form4a_165753457810786.xml","form_type":"4/A","original_submission_date":"2022-05-20"}},{"id":2261403,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T20:08:40.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":14612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in twelve equal monthly installments commencing on June 18, 2022."}],"balance_after":14612,"derivative":{"exercise_price":11.45,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":14612},"source":{"system":"sec-edgar","filing":"0001628280-22-015031","document":"wf-form4_165307729475114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015031/wf-form4_165307729475114.xml","form_type":"4"}},{"id":2261402,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-20T20:08:40.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":8733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant."}],"balance_after":8733,"derivative":{"underlying":"Common Shares","underlying_shares":8733},"source":{"system":"sec-edgar","filing":"0001628280-22-015031","document":"wf-form4_165307729475114.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022015031/wf-form4_165307729475114.xml","form_type":"4"}},{"id":2665531,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":85666,"kind":"person","name":"Jayne David R.W.","position":1,"cik":"0001838242","reported_name":"Jayne David R.W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T01:19:36.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":31347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in twelve equal monthly installments commencing on July 14, 2021."}],"balance_after":31347,"derivative":{"exercise_price":12.86,"expiration_date":"2031-06-14","underlying":"Common Shares","underlying_shares":31347},"source":{"system":"sec-edgar","filing":"0001628280-21-012385","document":"wf-form4_162389275893099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021012385/wf-form4_162389275893099.xml","form_type":"4"}}]}